ctDNA Can Be Used For Patient Selection and Enrichment, But Not As Early Efficacy Endpoint, US FDA Says

 
• By Sue Sutter
Selected person
Circulating tumor DNA can be used to select patients for clinical trials. • Source: Shutterstock

More from Clinical Trials

More from R&D